• Je něco špatně v tomto záznamu ?

Probe-based confocal laser endomicroscopy versus biopsies in the diagnostics of oesophageal and gastric lesions: A prospective, pathologist-blinded study

M. Kollar, J. Krajciova, L. Prefertusova, E. Sticova, J. Maluskova, Z. Vackova, J. Martinek

. 2020 ; 8 (4) : 436-443. [pub] 20200128

Jazyk angličtina Země Velká Británie

Typ dokumentu klinické zkoušky, srovnávací studie, časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc21020614

Grantová podpora
NV16-27648A MZ0 CEP - Centrální evidence projektů

BACKGROUND AND AIM: Probe-based confocal laser endomicroscopy (pCLE) provides real-time microscopic visualisation. Our aim was to compare the diagnostic accuracy of pCLE with standard biopsies in patients with visible oesophageal or gastric lesions. METHODS: This was a single-centre, prospective, pathologist-blinded study. Patients underwent high-resolution endoscopy, and lesions were examined by pCLE followed by standard biopsies. A definitive diagnosis was determined from resection specimen. Main outcomes were overall diagnostic accuracy, sensitivity, specificity and positive and negative predictive values. RESULTS: We examined 74 lesions in 67 patients. Definitive diagnoses revealed 34 malignant and 40 non-malignant lesions. pCLE diagnosis was correct in 89.2% (66/74), while diagnosis based on biopsy was correct in 85% (57/67; p = 0.6). The overall diagnostic accuracy of biopsies was 85% (76-94%) and that of pCLE was 89% (79-96%). pCLE correctly diagnosed malignant lesions, comprising oesophageal adenocarcinoma, oesophageal squamous-cell cancer or gastric adenocarcinoma, in 88.2% (30/34) of cases, while biopsy was correctly diagnosed in 75.9% (22/29; p = 0.3). Sensitivity and specificity to diagnose a malignant lesion were 75.9% (95% confidence interval (CI) 56-89%) and 100% (95% CI 90-100%) for biopsies and 88.2% (95% CI 72-97%) and 92% (95% CI 79-98%) for pCLE. No differences between biopsies and pCLE were found with regard to sensitivity, specificity to diagnose dysplastic and benign lesions (p > 0.2). CONCLUSION: pCLE provides satisfactory diagnostic accuracy comparable with standard biopsies in patients with oesophageal or gastric lesions. ClinicalTrials.gov identifier: NCT0292049).

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21020614
003      
CZ-PrNML
005      
20210830102237.0
007      
ta
008      
210728s2020 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1177/2050640620904865 $2 doi
035    __
$a (PubMed)32213027
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Kollar, Marek $u Department of Pathology, Institute for Clinical and Experimental Medicine (IKEM), Prague, Czech Republic $u Institute of Physiology, First Faculty of Medicine, Charles University, Prague, Czech Republic
245    10
$a Probe-based confocal laser endomicroscopy versus biopsies in the diagnostics of oesophageal and gastric lesions: A prospective, pathologist-blinded study / $c M. Kollar, J. Krajciova, L. Prefertusova, E. Sticova, J. Maluskova, Z. Vackova, J. Martinek
520    9_
$a BACKGROUND AND AIM: Probe-based confocal laser endomicroscopy (pCLE) provides real-time microscopic visualisation. Our aim was to compare the diagnostic accuracy of pCLE with standard biopsies in patients with visible oesophageal or gastric lesions. METHODS: This was a single-centre, prospective, pathologist-blinded study. Patients underwent high-resolution endoscopy, and lesions were examined by pCLE followed by standard biopsies. A definitive diagnosis was determined from resection specimen. Main outcomes were overall diagnostic accuracy, sensitivity, specificity and positive and negative predictive values. RESULTS: We examined 74 lesions in 67 patients. Definitive diagnoses revealed 34 malignant and 40 non-malignant lesions. pCLE diagnosis was correct in 89.2% (66/74), while diagnosis based on biopsy was correct in 85% (57/67; p = 0.6). The overall diagnostic accuracy of biopsies was 85% (76-94%) and that of pCLE was 89% (79-96%). pCLE correctly diagnosed malignant lesions, comprising oesophageal adenocarcinoma, oesophageal squamous-cell cancer or gastric adenocarcinoma, in 88.2% (30/34) of cases, while biopsy was correctly diagnosed in 75.9% (22/29; p = 0.3). Sensitivity and specificity to diagnose a malignant lesion were 75.9% (95% confidence interval (CI) 56-89%) and 100% (95% CI 90-100%) for biopsies and 88.2% (95% CI 72-97%) and 92% (95% CI 79-98%) for pCLE. No differences between biopsies and pCLE were found with regard to sensitivity, specificity to diagnose dysplastic and benign lesions (p > 0.2). CONCLUSION: pCLE provides satisfactory diagnostic accuracy comparable with standard biopsies in patients with oesophageal or gastric lesions. ClinicalTrials.gov identifier: NCT0292049).
650    _2
$a adenokarcinom $x diagnóza $x patologie $7 D000230
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a biopsie $x statistika a číselné údaje $7 D001706
650    _2
$a spinocelulární karcinom $x diagnóza $x patologie $7 D002294
650    _2
$a gastrointestinální endoskopie $x přístrojové vybavení $x metody $x statistika a číselné údaje $7 D016099
650    _2
$a sliznice jícnu $x diagnostické zobrazování $x patologie $7 D000071041
650    _2
$a nádory jícnu $x diagnóza $x patologie $7 D004938
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a žaludeční sliznice $x diagnostické zobrazování $x patologie $7 D005753
650    _2
$a lidé $7 D006801
650    _2
$a lasery $7 D007834
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a konfokální mikroskopie $x přístrojové vybavení $x metody $x statistika a číselné údaje $7 D018613
650    _2
$a lidé středního věku $7 D008875
650    _2
$a prospektivní studie $7 D011446
650    _2
$a senzitivita a specificita $7 D012680
650    _2
$a nádory žaludku $x diagnóza $x patologie $7 D013274
655    _2
$a klinické zkoušky $7 D016430
655    _2
$a srovnávací studie $7 D003160
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Krajciova, Jana $u Department of Hepatogastroenterology, IKEM, Prague, Czech Republic $u Institute of Physiology, First Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Prefertusova, Lucia $u Department of Pathology, Institute for Clinical and Experimental Medicine (IKEM), Prague, Czech Republic
700    1_
$a Sticova, Eva $u Department of Pathology, Institute for Clinical and Experimental Medicine (IKEM), Prague, Czech Republic
700    1_
$a Maluskova, Jana $u Department of Pathology, Institute for Clinical and Experimental Medicine (IKEM), Prague, Czech Republic
700    1_
$a Vackova, Zuzana $u Department of Hepatogastroenterology, IKEM, Prague, Czech Republic $u Institute of Physiology, First Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Martinek, Jan $u Department of Hepatogastroenterology, IKEM, Prague, Czech Republic $u Institute of Physiology, First Faculty of Medicine, Charles University, Prague, Czech Republic
773    0_
$w MED00188834 $t United European gastroenterology journal $x 2050-6414 $g Roč. 8, č. 4 (2020), s. 436-443
856    41
$u https://pubmed.ncbi.nlm.nih.gov/32213027 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20210728 $b ABA008
991    __
$a 20210830102237 $b ABA008
999    __
$a ok $b bmc $g 1691233 $s 1141060
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 8 $c 4 $d 436-443 $e 20200128 $i 2050-6414 $m United European gastroenterology journal $n United European Gastroenterol J $x MED00188834
GRA    __
$a NV16-27648A $p MZ0
LZP    __
$a Pubmed-20210728

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...